Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance

Authors

Jason R. Andrews MD, University School of Medicine, Stanford, CA, USA
Stephen Baker, Department of Medicine, University of Cambridge, Cambridge, UK
Florian Marks, Department of Medicine, University of Cambridge, Cambridge, UK
Marcella Alsan, Research, Stanford University, Stanford, CA, USA
Denise Garrett, Sabin Vaccine Institute, Washington, DC, USA
Bruce G. Gellin, Sabin Vaccine Institute, Washington, DC, USA
Samir K. Saha, Dhaka Shishu Hospital, Dhaka, Bangladesh
Farah Naz Qamar, Aga Khan UniversityFollow
Mohammad Tahir Yousafzai, Aga Khan UniversityFollow

Document Type

Article

Department

Paediatrics and Child Health

Publication (Name of Journal)

The Lancet. Infectious diseases

DOI

10.1016/S1473-3099(18)30350-5

Recommended Citation

Andrews MD, J. R., Baker, S., Marks, F., Alsan, M., Garrett, D., Gellin, B. G., Saha, S. K., Qamar, F. N., Yousafzai, M. T. (2019). Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. The Lancet. Infectious diseases, 19(1), e26-e30.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_obstet_gynaecol/195